Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their mult...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f210d43dd16945698f52750385c345af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f210d43dd16945698f52750385c345af |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f210d43dd16945698f52750385c345af2021-11-17T07:03:17ZReactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword2296-418510.3389/fbioe.2021.784612https://doaj.org/article/f210d43dd16945698f52750385c345af2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.784612/fullhttps://doaj.org/toc/2296-4185Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their multiple roles, which may vary with their concentration, location and the immune microenvironment they are in. Here, we have reviewed the reported effects of ROS on macrophage polarization, immune checkpoint blocking (ICB) therapy, T cell activation and expansion, as well as the induction of immunogenic cell death. A majority of reports are indicating detrimental effects of ROS, but it is unadvisable to simply scavenge them because of their pleiotropic effects in most occasions (except in T cell activation and expansion where ROS are generally undesirable). Therefore, clinical success will need a clearer illustration of their multi-faced functions, as well as more advanced technologies to tune ROS level with high spatiotemporal control and species-specificity. With such progresses, the efficacy of current immunotherapies will be greatly improved by combining with ROS-targeted therapies.Jie WangJie WangNing LiuHongfei JiangHongfei JiangQian LiDongming XingDongming XingDongming XingFrontiers Media S.A.articleROSimmunotherapymacrophage polarizationT cell activationimmunogenic cell deathBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
ROS immunotherapy macrophage polarization T cell activation immunogenic cell death Biotechnology TP248.13-248.65 |
spellingShingle |
ROS immunotherapy macrophage polarization T cell activation immunogenic cell death Biotechnology TP248.13-248.65 Jie Wang Jie Wang Ning Liu Hongfei Jiang Hongfei Jiang Qian Li Dongming Xing Dongming Xing Dongming Xing Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
description |
Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their multiple roles, which may vary with their concentration, location and the immune microenvironment they are in. Here, we have reviewed the reported effects of ROS on macrophage polarization, immune checkpoint blocking (ICB) therapy, T cell activation and expansion, as well as the induction of immunogenic cell death. A majority of reports are indicating detrimental effects of ROS, but it is unadvisable to simply scavenge them because of their pleiotropic effects in most occasions (except in T cell activation and expansion where ROS are generally undesirable). Therefore, clinical success will need a clearer illustration of their multi-faced functions, as well as more advanced technologies to tune ROS level with high spatiotemporal control and species-specificity. With such progresses, the efficacy of current immunotherapies will be greatly improved by combining with ROS-targeted therapies. |
format |
article |
author |
Jie Wang Jie Wang Ning Liu Hongfei Jiang Hongfei Jiang Qian Li Dongming Xing Dongming Xing Dongming Xing |
author_facet |
Jie Wang Jie Wang Ning Liu Hongfei Jiang Hongfei Jiang Qian Li Dongming Xing Dongming Xing Dongming Xing |
author_sort |
Jie Wang |
title |
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
title_short |
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
title_full |
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
title_fullStr |
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
title_full_unstemmed |
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword |
title_sort |
reactive oxygen species in anticancer immunity: a double-edged sword |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/f210d43dd16945698f52750385c345af |
work_keys_str_mv |
AT jiewang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT jiewang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT ningliu reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT hongfeijiang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT hongfeijiang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT qianli reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword |
_version_ |
1718425900310069248 |